Standard Biotools | FLDM - Cash And Equivalent


Standard Biotools reported $267.49M in Cash and Equivalent for its fiscal quarter ending in September of 2026.





Cash And Equivalent Change Date
Agilent USD 1.76B 49M Jun/2026
Becton, Dickinson and Co. USD 725M 17M Sep/2026
Bio-Rad Laboratories USD 465.3M 51.7M Sep/2026
Bruker USD 184.9M 51.5M Jun/2026
Danaher USD 5.68B 1.33B Sep/2026
Illumina USD 1.29B 249M Sep/2026
Myriad Genetics USD 115.2M 9.2M Jun/2026
Nikon Corporation JPY 158.04B 6.7B Mar/2026
Pacific Biosciences Of California USD 55.91M 5.1M Sep/2026
Revvity USD 592.8M 430.14M Sep/2026
Roche Holding CHF 7.55B 579M Jun/2025
Sony JPY 2.01T 160.68B Sep/2026
Standard Biotools USD 267.49M 2.54M Sep/2026
Thermo Fisher Scientific USD 5.46B 1.4B Sep/2026
Waters USD 593M 54M Sep/2026